Skip to content

Clinical trials

Recruiting Dementia trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dementia Status: Recruiting Country / region: Australia Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20213
20231
20242
20255
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting14

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb3
Washington University School of Medicine2
Bespoke Clinical Research1
Center for Eye Research Australia1
Eli Lilly and Company1
GlaxoSmithKline1
Monash University1
Novartis Pharmaceuticals1
Stichting International Registry for Alzheimer's Disease and other Dementias Foundation1
University of Tasmania1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dementia14
Alzheimer Disease12
Cognitive Dysfunction5
Neurodegenerative Diseases3
Brain Diseases1
Cardiovascular Diseases1
Central Nervous System Diseases1
Dementia, Vascular1
Diabetes Mellitus, Type 21
Frontotemporal Dementia1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.